About Long Hill Capital
Long Hill Capital is a venture capital firm founded in 2016. It is primarily based out of Shanghai, China. As of Nov 2025, Long Hill Capital has invested in 37 companies. It primarily invests in Series A round in China based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and High Tech. Most recently it participated in the $***** Seed round of FUSIONTECH A lot of funds co-invest with Long Hill Capital, with names like BioTrack Capital sharing a substantial percentage of its portfolio. Long Hill Capital has team of 7 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Long Hill Capital's List of Top Investments
Long Hill Capital has a portfolio of 37 companies, one of which is a Unicorn. Their most notable investments are in Aibo Medical and Lab Direct.Their portfolio spans across China, United States and India. They have invested in HealthTech, Enterprise Applications, High Tech and 14 other sectors, across stages such as Series A, Series B and 3 more. Here is the list of top investments by Long Hill Capital:Provider of integrated online and offline Chinese medicine services. It offers a comprehensive healthcare solution encompassing diagnosis, treatment, and health management. The company utilizes a digital platform to expand access to quality care, connecting patients with a network of practitioners. A key focus is on the training and development of medical professionals through mentorship programs and the standardization of diagnostic procedures. It also develops and distributes proprietary pharmaceutical products.
Key facts about Gu Sheng Tang
- Founded Year: 2010
- Location: Guangzhou (China)
- Stage: Public
- Total Funding till date: $150M
- Employee Count: 104 as on Aug 31, 2026
- Investors: F-Prime Capital, Eight Roads Ventures and 2 Others
- Latest Funding Round: Series D, Aug 03, 2017, $*****
- Highlight: Public
Developer of protein degradation (TPD) drugs for solid tumors and inflammatory diseases. The company focused on developing novel targeted protein degradation (TPD) drugs, across multiple therapeutic areas including oncology and immunology.
Key facts about GluBio Therapeutics
- Founded Year: 2021
- Location: San Diego (United States)
- Stage: Series A
- Total Funding till date: $72M
- Employee Count: 12 as on Aug 31, 2026
- Investors: Qiming Venture Partners, Kaitai Capital Management and 2 Others
- Latest Funding Round: Series A, Aug 01, 2022, $*****
{}
Key facts about Dongfang Qiyin
- Founded Year: 2007
- Location: Shenzhen (China)
- Stage: Series D
- Total Funding till date: $113M
- Employee Count: 170 as on Aug 31, 2026
- Investors: Temasek, F-Prime Capital and 5 Others
- Latest Funding Round: Series D, Mar 07, 2022, $*****
- Highlight: Editors' Pick
4. Jiandanxinli
Provider of an online platform for psychological counseling and consultation. It claims to have over 300 trained psychologists, counselors, and mental service providers on its platform. It enables users to speak to a counselor by telephone, online groups, psychological assessment, and more.
Key facts about Jiandanxinli
- Founded Year: 2014
- Location: Beijing (China)
- Stage: Series B
- Total Funding till date: $32.6M
- Employee Count: 88 as on Aug 31, 2026
- Investors: Prosperity7 Ventures, New Enterprise Associates and 5 Others
- Latest Funding Round: Series B, Dec 09, 2021, $*****
- Highlight: Editors' Pick
5. LinkDoc
Provider of the oncology-focused database. It is a big data company that is involved in medical information systems integration and application software development. It claims to have built a rich repository of cancer patients' medical records and comprehensive clinical data. It empowers evidence-based, personalized cancer treatment in China by providing doctors with valuable analytics derived from its oncology database.
Key facts about LinkDoc
Long Hill Capital's Year-on-Year Investment Trends
Long Hill Capital has invested in 37 companies over the last 9 years, with an average of 3 new investments annually in the last 5 years. In 2025, it made 1 investment. Its most recent first time investment was in Oushisheng (Beijing) Technology and most recent follow-on round was in FUSIONTECH.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 0 | 0 | 0 |
2023 | 2 | 1 | 3 |
2022 | 8 | 3 | 11 |
2021 | 6 | 3 | 9 |
2020 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
Long Hill Capital's Investments by Stage
Long Hill Capital has made 12 investments in Series A stage with an average round size of $21.3M, 5 investments in Series B stage with an average round size of $25.4M, 3 investments in Seed stage with an average round size of $18.9M, 2 investments in Angel stage with an average round size of $7.28M and 1 investment in Series C stage with an average round size of $15.4M.Stage of entry | No. of Investments |
|---|---|
Series A | 12 |
Series B | 5 |
Seed | 3 |
Angel | 2 |
Series C | 1 |
Note: We have considered here, only first round of investments
Long Hill Capital's Investments by Sector
Long Hill Capital has a diverse portfolio, with companies operating in the Healthcare, HealthTech, Consumer, Enterprise Applications and Life Sciences. Notably, it has invested in 18 Tech companies, 12 Consumer (B2C) companies, 12 Enterprise (B2B) companies and at least 8 companies focusing on Software.Sector | No. of Investments |
|---|---|
Healthcare | 9 |
HealthTech | 8 |
Consumer | 4 |
Enterprise Applications | 4 |
Life Sciences | 4 |
Others | 13 |
Note: We have considered here, only first round of investments
Long Hill Capital's Investments by Geography
Long Hill Capital has made most investments in China (20), followed by India where it has made 1 investment.Country | No. of Investments |
|---|---|
China | 20 |
India | 1 |
United States | 1 |
Note: We have considered here, only first round of investments
Long Hill Capital's recent investments
Long Hill Capital has not made any investment in 2026 so far.Here are the most recent investments by Long Hill Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 11, 2025 | China | Seed | 1435 | ||
Jun 08, 2023 | China | Seed | 4618 | [+4] | |
Apr 25, 2023 | China | Series A | 2653 | - | |
Mar 14, 2023 | China | Angel | 6177 | - | |
Dec 05, 2022 | China | Seed | 6244 | [+3] |
Unicorns in Long Hill Capital's Portfolio
Long Hill Capital has 1 unicorn in its portfolio - LinkDoc. The most recent unicorn in their portfolio is LinkDoc which became a unicorn in 2018, 8 years before Long Hill Capital first invested in it.Here is a list of unicorns in Long Hill Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
46 | Provider of the oncology-focused database | 2014 | Haidian | Series D | pvobmzq |
IPOs and Publicly Listed companies in Long Hill Capital's Portfolio
1 of Long Hill Capital's portfolio company became public - Gu Sheng Tang. It got listed on the Hong Kong Exchanges (HKG), in Dec 2021 at marketcap of $857MHere are Long Hill Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 10, 2021 | - | - | 5039 |
Acquired companies in Long Hill Capital's Portfolio
1 company from Long Hill Capital's portfolio has been acquired. The most recent acquisition was Lingwa in Jan 2018 by Beijing Freebee Electronic Commerce for $*****.Here are Long Hill Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 12, 2018 | Aug 21, 2017 | Series A | 1222 |
Team profile of Long Hill Capital
Long Hill Capital has a team of 7 members including 2 Partners and 2 Principals located in China and United States. Long Hill Capital's team sits on the board of 2 companies.Here is a list of all team members in Long Hill Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Jing an | |||
Partner | Shanghai | - | ||
Principal | Jing an | - | ||
Principal | Washington | - |
Co-investors of Long Hill Capital
Over the past 9 years, 50 investors have co-invested in Long Hill Capital's portfolio companies. This includes only funds.
- Invested before Long Hill Capital: Zhen Fund, Matrix Partners China and 6 others have invested in rounds before Long Hill Capital. There are 2 companies where Zhen Fund has invested before Long Hill Capital and 2 companies where Matrix Partners China has invested before Long Hill Capital.
- Top Co-investors of Long Hill Capital: 19 investors entered a company along with Long Hill Capital. These include investors like BioTrack Capital (2 companies).
- Invested after Long Hill Capital: A total of 23 investors have invested in Long Hill Capital's portfolio after their investments. Top Investors include Cenova (2 companies), Qiming Venture Partners (1 company) and Lilly Asia Ventures (1 company).
Recent News related to Long Hill Capital
•
Fortune Science and Technology Completes 50 Million Yuan Pre-A Round of FinancingSina•Nov 11, 2025•Long Hill Capital, Marathon Venture Partners
•
Fuxin Digital Technology secures 50 million RMB in Pre-A round financing to accelerate the implementation of its medical AI innovations.PEdaily•Nov 11, 2025•FUSIONTECH, Long Hill Capital
•
"Fuxin Technology Innovation" received 50 million yuan in angel round financing36Kr•Mar 14, 2023•FUSIONTECH, Long Hill Capital
•
Chinese smart wheelchair startup secures $14.8m in Series B roundNihon Keizai Shimbun•Jul 31, 2022•Robooter, 01VC, Lake Bleu Capital, BioTrack Capital and 2 others
•
"Aibo Medical Robot" received 120 million yuan in Pre-A round of financing36Kr•Mar 17, 2022•Aibo Medical, CDH, Changan Private Capital, EB Medical and 1 other
•
Digital medical service track adds additional financing, Yunkai Yamei completes 200 million yuan C round of financingPEdaily•Dec 23, 2021•InCarey, New Enterprise Associates, Long Hill Capital, Huagai Capital and 1 other
•
•
Wangshi Wisdom receives US$100 million in Series B and Series B+ financingPEdaily•Apr 12, 2021•StoneWise, Greater Bay Area Homeland Investments, Legend Capital, STONEWISE and 4 others
•
Long Hill raises $300m for third China VC fundAsian Venture Capital Journal•Apr 08, 2021•Long Hill Capital
•
Orient Speech Therapy Bags $23M Series C1 From Cenova CapitalVOLANEWS•Feb 05, 2021•Dongfang Qiyin, Cenova, NLVC, Long Hill Capital
